Sleep apnea syndrome (SAS) is a medical disorder affecting, 4% of men and 2% of women worldwide. This syndrome characterized by repetitive reductions of airflow during sleep due to the collapse of the pharyngeal airway, causing loud snoring, brief awakenings, hypoxemia and elevated blood pressure. Millions of sleep apnea patients suffer from excessive daytime sleepiness, headaches and hypertension. There is growing evidence that chronic sleep apnea runs in families, and is associated with increased morbidity and mortality. Sleep apnea is relatively unknown, with only about 15% diagnosed so far.Sleep apnea can only be diagnosed by a sleep study, costing up to 2,500.00. Unattended ambulatory studies, which are considered least expensive, are often unreliable. There is therefore a need for a low cost screening device, which may help screen the general population and locate potential